Newsy's Latest Health News

Moderna is testing its COVID-19 vaccine in children aged six months to 11 years, involving over 6,700 participants to find the safest dose. Pfizer and Johnson & Johnson are also conducting similar trials. AstraZeneca has agreed to supply 500,000 doses of its experimental COVID-19 treatment to the US, pending FDA approval. This treatment is distinct from AstraZeneca's vaccine, which some European countries have paused due to blood clot concerns. The report acknowledges Kaiser Health News for their contribution.

What age range is Moderna targeting in its COVID-19 vaccine trials?

• 2 to 5 years

• 6 months to 11 years

• 12 to 18 years

• 1 to 3 years

Which companies, besides Moderna, are testing COVID-19 vaccines in children?

• BioNTech and CureVac

• Sinovac and Sputnik V

• AstraZeneca and Novavax

• Pfizer and Johnson & Johnson

How many additional doses of its experimental treatment is AstraZeneca planning to supply to the US?

• 100,000 doses

• 1,000,000 doses

• 200,000 doses

• 500,000 doses

What is required for AstraZeneca's treatment to be supplied to the US?

• A partnership with Pfizer

• A new clinical trial

• Emergency use authorization from the FDA

• Approval from the European Medicines Agency

Why have some European countries suspended the use of AstraZeneca's vaccine?

• Lack of efficacy

• High cost

• Storage issues

• Blood clotting concerns